Angiodynamics Inc
Current role
ANGO
Chad T. Campbell
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Chad T. Campbell
The proxy statement of Angiodynamics Inc reports total compensation of $1,012,551 for Chad T. Campbell in fiscal 2024, including a base salary of $353,176. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Angiodynamics Inc (ANGO)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Angiodynamics Inc
Other people whose current roles at this company are on record from its filings.
- Eric Honroth CEO, Board Member
- Former EVP CFO
- Stephen A. Trowbridge CFO
- Dennis Meteny Board Member
- Eileen O. Auen Board Member
- James Clemmer Board Member
- Jan Stern Reed Board Member
- Karen A. Licitra Board Member
- Lorinda A. Burgess Board Member
- Lorinda Burgess Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Angiodynamics Inc (ANGO) | SVP & GM, Global Oncology and Vascular Access | $353,176 | $1,012,551 |
| 2023 | Angiodynamics Inc (ANGO) | SVP & GM, Global Oncology and Vascular Access | $339,749 | $778,036 |
| 2022 | Angiodynamics Inc (ANGO) | SVP & GM, Global Oncology and Vascular Access | $324,146 | $1,030,609 |
| 2021 | Angiodynamics Inc (ANGO) | SVP & GM, Vascular Access and Oncology | $314,001 | $853,864 |
Recent activity
No call appearances or filed executive changes recorded yet.